Colleen Ramser Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 914 E. Broadway, 3rd Floor, KY 40204 Phone: 502-589-8600 Fax: 502-589-8771 |
Ashley Hardin Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 101 Adanta Cir, Albany, KY 42602 Phone: 606-387-7635 |
Judy Denney Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 101 Adanta Cir, Albany, KY 42602 Phone: 606-387-7635 Fax: 606-387-5638 |
Mindy Blakeman Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 101 Adanta Cir, Albany, KY 42602 Phone: 606-387-7635 Fax: 606-387-5638 |
Sarah Luann Wilson-browning, LPCC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 169 Middle School Rd, Albany, KY 42602 Phone: 844-435-0900 Fax: 270-858-4029 |
Lee Parrigin, LPCC, CADC Counselor - Professional Medicare: Medicare Enrolled Practice Location: 107 Foothills Academy Spur, Albany, KY 42602 Phone: 606-387-4673 |
Mr. Richard York, LPCC Counselor - Professional Medicare: Medicare Enrolled Practice Location: 819 3rd St, Albany, KY 42602 Phone: 844-435-0900 Fax: 270-858-4029 |
Jessica Butler, LPCC Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 101 Adanta Cir, Albany, KY 42602 Phone: 606-387-7635 |
Christopher D Moons, LPCC Counselor - Professional Medicare: Medicare Enrolled Practice Location: 169 Middle School Rd, Albany, KY 42602 Phone: 844-435-0900 Fax: 270-858-4029 |
Jessica Hancock Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 101 Adanta Cir, Albany, KY 42602 Phone: 606-387-7635 Fax: 606-678-5296 |
Libby Burris, CADC Counselor - Addiction (Substance Use Disorder) Medicare: Medicare Enrolled Practice Location: 101 Adanta Cir, Albany, KY 42602 Phone: 606-387-7635 |
Kristie Moreland Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 101 Adanta Cir, Albany, KY 42602 Phone: 606-679-4782 |
Rosa Brummett, LPCA MRC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 801 Tennessee Rd Ste J, Albany, KY 42602 Phone: 606-307-3201 |
Mrs. April Nicole Speck, L.P.C.C. Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 250 Burkesville Rd, Albany, KY 42602 Phone: 606-306-2222 |
Tammy Flowers Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 101 Adanta Cir, Albany, KY 42602 Phone: 606-387-7635 |
Chastity Polston, LPCA Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 401 Central St, Albany, KY 42602 Phone: 606-306-4977 |
Lisa Beatty Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 101 Adanta Cir, Albany, KY 42602 Phone: 606-387-7635 Fax: 606-387-5638 |
James C Robinson, LPCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 408 Harrisburg Hill Rd, Alexandria, KY 41001 Phone: 513-518-0356 |
Christina Howard, LCSW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 8333 Alexandria Pike, Alexandria, KY 41001 Phone: 859-462-1685 |
Tammy Siry, LPCC-S Counselor Medicare: Not Enrolled in Medicare Practice Location: 23 Sheridan Dr, Alexandria, KY 41001 Phone: 859-620-8209 |
News Archive
Methicillin-resistant Staphylococcus aureus (MRSA) is a major problem in nursing homes with one in four residents carrying the bacteria, a study by Queen's University Belfast and Antrim Area Hospital has found.
Stenting is safe and effective and superior to balloon angioplasty for treatment of venous stenosis in patients with deep vein thrombosis, according to results from EVISTA-DVT, presented today as a Late-Breaking Clinical Trial at the Society for Cardiovascular Angiography and Interventions 2011 Scientific Sessions in Baltimore.
While much attention has focused on the potential for severe respiratory complications and unfavorable outcomes from the COVID-19 pandemic among patients with Parkinson's disease (PD), the impact extends beyond these threats.
Neurocrine Biosciences, Inc. announced today that NBI-98854, a highly selective small molecule VMAT2 inhibitor, showed a statistically significant reduction in tardive dyskinesia during the six weeks of placebo-controlled treatment in the Kinect 3 clinical trial. This Phase III trial included moderate to severe tardive dyskinesia patients with underlying schizophrenia, schizoaffective disorder, bipolar or major depressive disorder.
› Verified 3 days ago